Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Parker Snure
Parker Snure of Raymond James asked 4 questions on 2 earnings calls at one company Tellvest tracks, from 2026 Q2 to 2026 Q3. Snure's most common topics are Regulation Policy, Subscriber Growth and Competitive Dynamics. Snure's most recent question was on Oscar Health, Inc.'s 2026 Q3 call, about Cost Pressure and Guidance Reliability.
Period: Reporting periods mapped to calendar 2026 Q2 – 2026 Q3 (2 quarters).
- Questions
- 4on tracked calls
- Challenge rate
- 25%1 of 4 questionsLimited sample
- Companies
- 1questioned at least once
- Reporting periods
- 2with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right. See how we grade analysts on earnings-call questions.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 4 of 4 questions from 1 company
OSCROscar Health, Inc.4 questions · 2 reporting periods · 1 of 4 challenging
Calendar 2026 Q3
curious if you view these procedural measures as being a material driver in this year's annual enrollment process
Show response
Said the checks will slow the start and dent broker productivity, but some members will drop off while new entrants offset, leaving the market flat.
It appears that it implies actually a decline in actual medical costs sequentially.
Show response
Disputed the math, putting implied Q4 MLR in the low 90s versus an underlying Q3 near 84.8, and said the risk adjustment benefit comes with claims.
Calendar 2026 Q2
Just curious on how you guys are thinking about the 2027 rate cycle.
Show response
CEO called pricing rational so far and said Oscar can still change product and pricing if rules shift.
how are you thinking about the overall ACA market enrollment in 2027 at this point in time?
Show response
CEO said program integrity and subsidy effects are largely built in and the market can stay stable or grow.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| OSCR Oscar Health, Inc. | 4 | 25%1 of 4 questions |
- OSCROscar Health, Inc. · 4 questions25%1 of 4 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2026 Q2 | 2 | 0%none of 2 questions | 1 |
| 2026 Q3 | 2 | 50%1 of 2 questions | 1 |
- 2026 Q22 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2026 Q32 questions · challenge rate 50% (1 of 2 questions) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Regulation Policy2
- Subscriber Growth2
- Cost Pressure1
- Guidance Reliability1
- Pricing1
- Competitive Dynamics1